Literature DB >> 8077733

The novel epidemic strain O139 is closely related to the pandemic strain O1 of Vibrio cholerae.

P Berche1, C Poyart, E Abachin, H Lelievre, J Vandepitte, A Dodin, J M Fournier.   

Abstract

A new Vibrio cholerae serogroup O139 strain of unknown origin recently emerged in India and Bangladesh, causing a major outbreak of cholera. The genetic relationship between this epidemic strain and the O1 strain responsible for the 7th pandemic of cholera was studied by analyzing the DNA polymorphism of V. cholerae by pulsed-field gel electrophoresis and arbitrarily primed polymerase chain reaction. The restriction patterns of the reference strain O139 Bengal and 10 wild O139 strains isolated early in the Indian outbreak strikingly resemble that of the pandemic O1 strain of V. cholerae El Tor, thus suggesting a close genetic relationship among these strains. This similarity contrasts with the genetic heterogeneity of sporadic non-O1 strains isolated in various parts of the world. Study results strongly suggest that the new epidemic O139 strain is closely related to and might be derived from the pandemic O1 strain of V. cholerae.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8077733     DOI: 10.1093/infdis/170.3.701

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  28 in total

1.  Cloning and sequencing of the genes downstream of the wbf gene cluster of Vibrio cholerae serogroup O139 and analysis of the junction genes in other serogroups.

Authors:  S Sozhamannan; Y K Deng; M Li; A Sulakvelidze; J B Kaper; J A Johnson; G B Nair; J G Morris
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

2.  Resurgent Vibrio cholerae O139: rearrangement of cholera toxin genetic elements and amplification of rrn operon.

Authors:  G Khetawat; R K Bhadra; S Nandi; J Das
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

3.  Vibrio cholerae O139 Bengal: combined physical and genetic map and comparative analysis with the genome of V. cholerae O1.

Authors:  G Khetawat; R K Bhadra; S Kar; J Das
Journal:  J Bacteriol       Date:  1998-09       Impact factor: 3.490

4.  Isolation and characterization of rugose form of Vibrio cholerae O139 strain MO10.

Authors:  Y Mizunoe; S N Wai; A Takade; S I Yoshida
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

5.  Investigation of the roles of toxin-coregulated pili and mannose-sensitive hemagglutinin pili in the pathogenesis of Vibrio cholerae O139 infection.

Authors:  C O Tacket; R K Taylor; G Losonsky; Y Lim; J P Nataro; J B Kaper; M M Levine
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

6.  2,3-butanediol synthesis and the emergence of the Vibrio cholerae El Tor biotype.

Authors:  Sang Sun Yoon; John J Mekalanos
Journal:  Infect Immun       Date:  2006-10-02       Impact factor: 3.441

7.  Comparative genomic analyses of the vibrio pathogenicity island and cholera toxin prophage regions in nonepidemic serogroup strains of Vibrio cholerae.

Authors:  Manrong Li; Mamuka Kotetishvili; Yuansha Chen; Shanmuga Sozhamannan
Journal:  Appl Environ Microbiol       Date:  2003-03       Impact factor: 4.792

8.  Multilocus sequence typing has better discriminatory ability for typing Vibrio cholerae than does pulsed-field gel electrophoresis and provides a measure of phylogenetic relatedness.

Authors:  Mamuka Kotetishvili; O Colin Stine; Yuansha Chen; Arnold Kreger; Alexander Sulakvelidze; Shanmuga Sozhamannan; J Glenn Morris
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

9.  Emergence and evolution of Vibrio cholerae O139.

Authors:  Shah M Faruque; David A Sack; R Bradley Sack; Rita R Colwell; Yoshifumi Takeda; G Balakrish Nair
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-21       Impact factor: 11.205

10.  Structural and functional characterization of IS1358 from Vibrio cholerae.

Authors:  S Dumontier; P Trieu-Cuot; P Berche
Journal:  J Bacteriol       Date:  1998-12       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.